Lymphoma Archives - Page 3 of 5

Doxorubicin disrupts the immune system to cause heart toxicity: The drug targets enzymes that control the immune response and spleen macrophages

Doxorubicin is a chemotherapy drug widely used in ovarian, bladder, lung, thyroid and stomach cancers, but it carries a harmful

Researchers have reported the results of the first randomised clinical trial to test a novel strategy involving waking up and

The therapeutic potential of human induced pluripotent stem cells (iPSCs), which are capable of becoming almost any type of cell

Patients with colorectal cancer tumors on the right side may have poorer five-year survival rates than those whose tumors are

SEATTLE, July 9, 2018 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ:CTIC) and Servier today announced that the pivotal Phase III trial

University of Otago research provides insights into an underlying mechanism that could explain why new cancer therapies to help treat

Machine learning using real-time symptom reports can accurately detect lymphedema, a distressing side effect of breast cancer treatment that is

Bioengineers may be able to use the unique mechanical properties of diseased cells, such as metastatic cancer cells, to help

Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling

New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also